Skip to main content

Seth Rogen Is Launching His Own Marijuana Brand

AUSTIN, TEXAS – MARCH 11: Seth Rogen and Evan Goldberg attend the ‘Good Boys’ Premiere 2019 SXSW Conference and Festivals at Paramount Theatre on March 11, 2019 in Austin, Texas. (Photo by Matt Winkelmeyer/Getty Images for SXSW)

Getty

Seth Rogen and Evan Goldberg have worked together on films like Superbad, The Interview, and Pineapple Express. Now the duo is embarking on a different type of project: a marijuana company.

“Houseplant is a passion we’ve brought to life through drive and dedication,” said Seth Rogen, Co-Founder of Houseplant.  “Every decision we’ve made for the business reflects the years of education, first-hand experience and respect we have for cannabis.”

Based in Canada, the home country of both men, the brand’s first product is experienced to be called Houseplant Sativa and will be available in early April in British Columbia and surrounding areas. Afterward it plans to launch Houseplant Hybrid and Houseplant Indica, eventually followed by pre-rolled joints and gels. The cannabis it sells will come from Canada’s Canopy Growth, which also has a minority stake in the company.

“Houseplant represents years of product expertise and unmatched attention to detail within each strain that has been carefully selected and grown,” Canopy Growth said in a statement.“Commitment to cannabis quality begins with selecting the best genetics and doesn’t stop until the customer opens the jar. Canopy Growth has witnessed how carefully Houseplant has chosen each component of their offering to deliver the highest quality product to Canadians.”  

Rogen and Goldberg are fan from the first celebrities to join the cannabis space. Most recently, CJ Wallace, son of the Notorious B.I.G announced he was getting into cannabis with the launch of his brand Think Big, honoring his father.

In February both Martha Stewart and Willie Nelson also announced the launch of their own CBD brands. Like Rogen and Goldberg, Stewart is working with Canopy Growth on her line.

“I am delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living,”  Stewart said in a statement. “I’m especially looking forward to our first collaboration together, which will offer sensible products for people’s beloved pets.”

Martha’s favorite pot luck guest Snoop Dogg also has his own CBD line in the works through Canopy Growth. Called “Leafs by Snoop” his line is expected to be made specifically to treat anxiety in pets.

Canopy Growth is a leading cannabis company in Canada but the company does not currently sell any products in the United States.

The company’s stock is currently traded on the New York Stock Exchange as well as the Toronto Stock Exchange. The NY stock exchange, in particular, does not allow companies traded on it from engaging in an enterprise that’s illegal on a federal level, which marijuana currently is in the United States.

Last year the company received a late influx for cash from Constellation Brands, the parent company of a number of well-known alcohol brands including Ballast Point Brewing and Corona.

Original Article Source: https://www.forbes.com/sites/emilyprice/2019/03/28/seth-rogen-is-launching-his-own-marijuana-brand/

Comments

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...